Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Canal

Showing results (31-40 of 142) with videos related to

Pageof 15
Sort By:
Presse Medicale (Paris, France : 1983)|May 18, 1996
[Acute erythroblastopenia in children caused by parvovirus B 19]C Benezech, A Gomard, L Malafosse, et al.
Bulletin Du Cancer|February 5, 1999
[Irinotecan pharmacokinetics]G G Chabot, J Robert, F Lokiec, et al.
Bulletin Du Cancer|January 1, 1989
[Prognostic value of prostatic acid phosphatase in stage B and C prostatic cancer. Apropos of 84 cases]J L Guerin, P Canal, J Douchez, et al.
Pathologie-Biologie|March 1, 1981
[Determination of circulating ectopic beta HCG in solid tumors (author's transl)]P Canal, R Bugat, G Soula, et al.
Tumori|December 31, 1983
Biological appraisal of liver status in adenocarcinomasP Canal, R Bugat, P Fernet, et al.
Soins; La Revue De Reference Infirmiere|July 1, 1990
[Injectable anti-cancer drugs. Stocking, preparation and administration]F Pinguet, G Favre, P Canal, et al.
Bulletin Du Cancer|February 25, 1999
[Anticancer drugs pharmacokinetics update]P Canal, L Gautié, N Grégoire, et al.
Journal of Chromatography. A|September 16, 1999
Anthracycline analysis by capillary electrophoresis. Application to the analysis of daunorubicine in Kaposi sarcoma tumorN Siméon, E Chatelut, P Canal, et al.
Anti-Cancer Drugs|October 11, 2001
Combination of oxaliplatin and irinotecan on human colon cancer cell lines: activity in vitro and in vivoS Guichard, S Arnould, I Hennebelle, et al.
European Journal of Cancer (Oxford, England : 1990)|December 31, 2002
Cellular determinants of oxaliplatin sensitivity in colon cancer cell linesS Arnould, I Hennebelle, P Canal, et al.
Pageof 15

Showing results (31-40 of 142) with videos related to

Sort By:
Pageof 15
Presse Medicale (Paris, France : 1983)|May 18, 1996
[Acute erythroblastopenia in children caused by parvovirus B 19]C Benezech, A Gomard, L Malafosse, et al.
Bulletin Du Cancer|February 5, 1999
[Irinotecan pharmacokinetics]G G Chabot, J Robert, F Lokiec, et al.
Bulletin Du Cancer|January 1, 1989
[Prognostic value of prostatic acid phosphatase in stage B and C prostatic cancer. Apropos of 84 cases]J L Guerin, P Canal, J Douchez, et al.
Pathologie-Biologie|March 1, 1981
[Determination of circulating ectopic beta HCG in solid tumors (author's transl)]P Canal, R Bugat, G Soula, et al.
Tumori|December 31, 1983
Biological appraisal of liver status in adenocarcinomasP Canal, R Bugat, P Fernet, et al.
Soins; La Revue De Reference Infirmiere|July 1, 1990
[Injectable anti-cancer drugs. Stocking, preparation and administration]F Pinguet, G Favre, P Canal, et al.
Bulletin Du Cancer|February 25, 1999
[Anticancer drugs pharmacokinetics update]P Canal, L Gautié, N Grégoire, et al.
Journal of Chromatography. A|September 16, 1999
Anthracycline analysis by capillary electrophoresis. Application to the analysis of daunorubicine in Kaposi sarcoma tumorN Siméon, E Chatelut, P Canal, et al.
Anti-Cancer Drugs|October 11, 2001
Combination of oxaliplatin and irinotecan on human colon cancer cell lines: activity in vitro and in vivoS Guichard, S Arnould, I Hennebelle, et al.
European Journal of Cancer (Oxford, England : 1990)|December 31, 2002
Cellular determinants of oxaliplatin sensitivity in colon cancer cell linesS Arnould, I Hennebelle, P Canal, et al.
Pageof 15